HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$3.03
Day range
$3.01 - $3.34
Year range
$3.00 - $13.65
Market cap
16.09M USD
Avg Volume
150.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.60M | -65.91% |
Net income | -3.51M | 66.74% |
Net profit margin | — | — |
Earnings per share | -0.79 | 85.18% |
EBITDA | -3.53M | 66.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.51M | -66.02% |
Total assets | 17.13M | -49.38% |
Total liabilities | 10.78M | -51.82% |
Total equity | 6.35M | — |
Shares outstanding | 4.44M | — |
Price to book | 2.12 | — |
Return on assets | -43.22% | — |
Return on capital | -54.18% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.51M | 66.74% |
Cash from operations | -6.78M | 33.42% |
Cash from investing | — | — |
Cash from financing | 13.00K | -99.16% |
Net change in cash | -6.77M | 21.83% |
Free cash flow | -5.55M | 17.56% |
About
Founded
2011
Headquarters
Website
Employees
21
